Details of Host Protein
| Host Protein General Information (ID: PT0922) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein Name |
Retrotransposon-derived protein PEG10 (NME2)
|
Gene Name |
PEG10
|
||||||
| Host Species |
Homo sapiens
|
Uniprot Entry Name |
PEG10_HUMAN
|
||||||
| Subcellular Location |
Extracellular vesicle membrane Cytoplasm Nucleus
|
||||||||
| External Link | |||||||||
| NCBI Gene ID | |||||||||
| Uniprot ID | |||||||||
| Ensembl ID | |||||||||
| HGNC ID | |||||||||
| Function in Host |
Retrotransposon-derived protein that binds its own mRNA andself-assembles into virion-like capsids. Formsvirion-like extracellular vesicles that encapsulate their own mRNA andare released from cells, enabling intercellular transfer of PEG10 mRNA. Binds its own mRNA in the 5'-UTR region, in theregion near the boundary between the nucleocapsid (NC) and protease (PRO) coding sequences and in the beginning of the 3'-UTR region. Involved in placenta formation: required fortrophoblast stem cells differentiation. Involved at theimmediate early stage of adipocyte differentiation. Overexpressed in many cancers and enhances tumor progression: promotescell proliferation by driving cell cycle progression from G0/G1. Enhances cancer progression by inhibiting the TGF-beta signaling, possibly via interaction with the TGF-beta receptor ACVRL1. May bind to the5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basicprotein (MBP) promoter; additional evidences are however required toconfirm this result.
[1-5]
Click to Show/Hide
|
||||||||
| 3D Structure |
|
||||||||
| Full List of Virus RNA Interacting with This Protien | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNA Region: Not Specified Virus Region (hCoV-19/England/02/2020 ) | |||||||||
| RNA Region Details |
RNA Info
Click to show the detail information of this RNA binding region
|
[6] | |||||||
| Strains Name |
hCoV-19/England/02/2020
|
||||||||
| Strains Family |
Beta (B.1.351)
|
||||||||
| RNA Binding Region |
Not Specified Virus Region
|
||||||||
| Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
| Infection Cells | Calu-3 cells (Human lung cancer cell) (CVCL_0609 ) | ||||||||
| Cell Originated Tissue | Lung | ||||||||
| Infection Time | 24 h | ||||||||
| Interaction Score | P-adjust = 0.081 | ||||||||
| Method Description | UV protein-RNA crosslinking; RNA interactome capture (cRIC); RNA antisense purification coupled with mass spectrometry (RAP-MS) | ||||||||




